Literature DB >> 18541643

Revisiting depression in palliative care settings: the need to focus on clinical utility over validity.

J L Reeve1, M Lloyd-Williams, C Dowrick.   

Abstract

OBJECTIVE: To review the literature on depression in palliative care patients to identify implications for development of clinical practice and individual patient care.
METHOD: A qualitative review of depression prevalence studies in palliative care settings. We explore the utility of existing prevalence studies for clinical practice through testing two hypotheses: that high prevalence rates are associated with increased risk factors in study samples, and that poor methodological quality of the studies artefactually inflate prevalence estimates. Eighteen studies were identified in the search and included in this review.
RESULTS: Risk factors may contribute to depression prevalence but through a complex interaction of factors making individual risk levels hard to determine. Measurement artefact cannot, alone, account for elevated levels of depression in this population but may contribute to imprecision. The importance of organic decline as a potential confounding variable is highlighted.
CONCLUSION: Future research into the causes and prevalence of depression should adopt longitudinal approaches using large samples, and consider the impact of organic disorder as an important confounding factor. Clinical practice and care of individual patients may be better supported by development of a prognostic index considering the predictive power of depressive symptoms and risk factors on well-being.

Entities:  

Mesh:

Year:  2008        PMID: 18541643     DOI: 10.1177/0269216307087953

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  8 in total

1.  Qualities of fatigue and associated chronic conditions among older adults.

Authors:  Susan E Hardy; Stephanie A Studenski
Journal:  J Pain Symptom Manage       Date:  2010-06       Impact factor: 3.612

2.  How family physicians address diagnosis and management of depression in palliative care patients.

Authors:  Franca Warmenhoven; Eric van Rijswijk; Elise van Hoogstraten; Karel van Spaendonck; Peter Lucassen; Judith Prins; Kris Vissers; Chris van Weel
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

3.  Frequency of depression among oncology outpatients and association with other symptoms.

Authors:  Wadih Rhondali; Elise Perceau; Julien Berthiller; Pierre Saltel; Veronique Trillet-Lenoir; Olivier Tredan; Jean-Pierre Coulon; Eduardo Bruera; Marilene Filbet
Journal:  Support Care Cancer       Date:  2012-02-17       Impact factor: 3.603

4.  Depressive disorder in the last phase of life in patients with cardiovascular disease, cancer, and COPD: data from a 20-year follow-up period in general practice.

Authors:  Franca Warmenhoven; Hans Bor; Peter Lucassen; Kris Vissers; Chris van Weel; Judith Prins; Henk Schers
Journal:  Br J Gen Pract       Date:  2013-05       Impact factor: 5.386

5.  The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients.

Authors:  Franca Warmenhoven; Eric van Rijswijk; Yvonne Engels; Cornelis Kan; Judith Prins; Chris van Weel; Kris Vissers
Journal:  Support Care Cancer       Date:  2011-01-18       Impact factor: 3.603

Review 6.  Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies.

Authors:  Alex J Mitchell; Motahare Yadegarfar; John Gill; Brendon Stubbs
Journal:  BJPsych Open       Date:  2016-03-09

7.  The Association Between Oxidative Stress and Depressive Symptom Scores in Elderly Population: A Repeated Panel Study.

Authors:  Changwoo Han; Youn-Hee Lim; Yun-Chul Hong
Journal:  J Prev Med Public Health       Date:  2016-08-23

Review 8.  Depressive Spectrum Disorders in Cancer: Diagnostic Issues and Intervention. A Critical Review.

Authors:  Rosangela Caruso; Maria GiuliaNanni; Michelle B Riba; Silvana Sabato; Luigi Grassi
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.